210 related articles for article (PubMed ID: 26592446)
21. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Takeuchi A; Nobumoto A; Tsuda M; Yokoyama A
Leukemia; 2015 Dec; 29(12):2296-306. PubMed ID: 26260387
[TBL] [Abstract][Full Text] [Related]
22. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
23. [Expression and Clinical Significance of N-cadherin in Bone Marrow Leukemic Cells Derived from Patients with Acute Leukemia].
Ma J; Liu YJ; Zhang QT; Yu QF; Zhang ZF; Zhang MY; Wang C; Gan SL; Chen SM; Cao WJ; Xie XS; Yan-Fang L; Liu LX; Wan DM; Wang F; Sun L; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1312-1318. PubMed ID: 27784348
[TBL] [Abstract][Full Text] [Related]
24. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
[No Abstract] [Full Text] [Related]
25. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
28. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T
Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140
[TBL] [Abstract][Full Text] [Related]
29. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
30. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.
Pizzo RJ; Azadniv M; Guo N; Acklin J; Lacagnina K; Coppage M; Liesveld JL
Exp Hematol; 2016 May; 44(5):378-89. PubMed ID: 26851308
[TBL] [Abstract][Full Text] [Related]
32. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
Becker PS
ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
[TBL] [Abstract][Full Text] [Related]
33. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
34. Correlation between CXCR4 and homing or engraftment of acute myelogenous leukemia.
Monaco G; Belmont JW; Konopleva M; Andreeff M; Tavor S; Petit I; Kollet O; Lapidot T
Cancer Res; 2004 Sep; 64(18):6832 author reply 6832-3. PubMed ID: 15375005
[No Abstract] [Full Text] [Related]
35. ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82.
Di Giacomo V; Tian TV; Mas A; Pecoraro M; Batlle-Morera L; Noya L; Martín-Caballero J; Ruberte J; Keyes WM
Oncogene; 2017 Aug; 36(31):4381-4392. PubMed ID: 28368419
[TBL] [Abstract][Full Text] [Related]
36. CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.
Wei Q; Zhang F; Richardson MM; Roy NH; Rodgers W; Liu Y; Zhao W; Fu C; Ding Y; Huang C; Chen Y; Sun Y; Ding L; Hu Y; Ma JX; Boulton ME; Pasula S; Wren JD; Tanaka S; Huang X; Thali M; Hämmerling GJ; Zhang XA
Circulation; 2014 Oct; 130(17):1493-504. PubMed ID: 25149363
[TBL] [Abstract][Full Text] [Related]
37. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
[TBL] [Abstract][Full Text] [Related]
38. CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.
Brault L; Rovó A; Decker S; Dierks C; Tzankov A; Schwaller J
Leukemia; 2014 Mar; 28(3):566-76. PubMed ID: 23817178
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
40. Morphology, differentiation and adhesion molecule expression changes of bone marrow mesenchymal stem cells from acute myeloid leukemia patients.
Chen Q; Yuan Y; Chen T
Mol Med Rep; 2014 Jan; 9(1):293-8. PubMed ID: 24220608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
